Retatrutide is currently still being evaluated in Phase 3 clinical trials, which means healthcare providers cannot yet prescribe it.[2] The drug is being developed by Eli Lilly and is being studied for potential treatment of obesity, type 2 diabetes, and fatty liver disease
If you think that peptides would be a good procedure for you to embark on, please schedule an appointment now with The Med Lounge
We do not allow the human consumption of our products
Convenient Local Care Located right here in Lewisburg, PA, our clinic offers flexible scheduling, a welcoming environment, and ongoing support throughout your journey
[2] [3] Weight loss appeared to continue throughout the 48-week period, suggesting the potential for further reductions with longer treatment durations, though this requires confirmation in Phase 3 studies
Its also worth noting that while the initial cost might be higher, the long-term benefits of using semaglutide for weight loss and managing diabetes can lead to overall cost savings in terms of reduced medical bills and improved quality of life